tobramycin has been researched along with Bronchiectasis in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.17) | 18.7374 |
1990's | 2 (8.33) | 18.2507 |
2000's | 9 (37.50) | 29.6817 |
2010's | 5 (20.83) | 24.3611 |
2020's | 7 (29.17) | 2.80 |
Authors | Studies |
---|---|
Ballmann, M; Blasi, F; Cantin, AM; Chalmers, JD; Elborn, JS; Haworth, CS; Murris-Espin, M; Tiddens, HAWM | 1 |
Cai, XJ; Chen, PY; Guan, WJ; Li, RK; Liang, ZA; Liu, XD; Luo, H; Ma, WL; Qu, JM; Song, YL; Tian, DB; Wei, LP; Xu, JF; Xu, XX; Zhang, GJ; Zhang, XJ; Zhang, YJ; Zhao, H; Zhong, NS; Zhu, SY | 1 |
Altenburg, J; Berk, Y; Boersma, WG; Bronsveld, I; de Kruif, MD; Heijerman, HGM; Rozemeijer, W; Snijders, D; Terpstra, LC | 1 |
Boersma, WG; Bronsveld, I; Heijerman, H; Terpstra, LC; van der Geest, D | 1 |
Angyalosi, G; Blasi, F; Chalmers, JD; Elborn, SJ; Goossens, H; Haworth, CS; Hill, AT; Loebinger, MR; Polverino, E; Tiddens, HA; Tunney, M; Zhou, W | 1 |
Angyalosi, G; Blasi, F; Chalmers, JD; Elborn, SJ; Goossens, H; Haworth, CS; Hill, AT; Loebinger, MR; Pathan, R; Polverino, E; Ringshausen, FC; Tiddens, HAWM; Tunney, M | 1 |
Fernández-Trujillo, L; Morales, EI; Sangiovanni, S | 1 |
Cetinkaya, E; Chousein, EGU; Çınarka, H; Gul, S; Özgül, MA; Tanriverdi, E; Turan, D; Yildirim, BZ | 1 |
Armstrong, R; Felix, LM; Grundy, S; Harrison, H; Lynes, D; Milan, SJ; Spencer, S | 1 |
Ferrer, A; Hernando, R; Montoro, B; Orriols, R; Terradas, S | 1 |
Akkerman, OW; Alffenaar, JW; de Boer, AH; Frijlink, HW; Hagedoorn, P; Hoppentocht, M; Kerstjens, HA; van der Werf, TS | 1 |
Rubin, BK | 1 |
Baker, WR; Barker, LM; Burns, JL; Gurgel, JL; Kenney, TF; MacLeod, DL; Moss, SC; Sutherland, JL | 1 |
Christodoulou, E; Eckhardt, BP; Nasr, SZ; Sakmar, E; Streetman, DS; Strouse, PJ | 1 |
Drobnic, ME; Ferrer, A; Montoro, JB; Orriols, R; Suñé, P | 1 |
Higashiyama, Y; Hirakata, Y; Kohno, S; Miyazaki, Y; Morinaga, Y; Nakamura, S; Ohno, H; Tashiro, T; Yanagihara, K | 1 |
Lobue, PA | 1 |
Scheinberg, P; Shore, E | 1 |
Bilton, D; Gotfried, M; Henig, N; Morrissey, B | 1 |
Machalski, M; Maślankiewicz, A; Szygua, J | 1 |
Anstine, D; Lakhdir, F; Neiberger, R; Slayton, W; Sleasman, J | 1 |
Abuan, T; Barker, AF; Couch, L; Fiel, SB; Gotfried, MH; Ilowite, J; Meyer, KC; O'Donnell, A; Quan, J; Sahn, SA; Smith, LJ; Stewart, JO; Tully, H; Van Dalfsen, J; Wells, CD | 1 |
He, G; Li, H; Xu, H | 1 |
Couch, LA | 1 |
4 review(s) available for tobramycin and Bronchiectasis
Article | Year |
---|---|
Bronchiectasis and inhaled tobramycin: A literature review.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2022 |
Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Topics: Administration, Inhalation; Bronchiectasis; Chronic Disease; Disease Progression; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin; Treatment Outcome | 2021 |
Dual antibiotics for bronchiectasis.
Topics: Adult; Anti-Bacterial Agents; Bronchiectasis; Ciprofloxacin; Gentamicins; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2018 |
Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Bronchiectasis; Clinical Trials as Topic; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Tobramycin | 2008 |
11 trial(s) available for tobramycin and Bronchiectasis
Article | Year |
---|---|
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Bronchiectasis; Double-Blind Method; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Tobramycin | 2023 |
Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Bronchodilator Agents; Chronic Disease; Humans; Tobramycin | 2023 |
Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Double-Blind Method; Forced Expiratory Volume; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2019 |
Efficacy and safety of TOBI Podhaler in
Topics: Administration, Inhalation; Adolescent; Adult; Bronchiectasis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2021 |
Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.
Topics: Administration, Inhalation; Administration, Intravenous; Aged; Anti-Bacterial Agents; Bronchiectasis; Ceftazidime; Female; Humans; Male; Prospective Studies; Pseudomonas aeruginosa; Tobramycin | 2015 |
The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Child; Cystic Fibrosis; Female; Humans; Lung; Male; Pilot Projects; Pseudomonas aeruginosa; Pseudomonas Infections; Spirometry; Sputum; Tobramycin; Tomography, X-Ray Computed | 2010 |
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis, Chronic; Cross-Over Studies; Double-Blind Method; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Quality of Life; Tobramycin | 2005 |
A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
Topics: Administration, Inhalation; Aged; Anti-Bacterial Agents; Bronchiectasis; Female; Humans; Lung Diseases; Male; Middle Aged; Pilot Projects; Pseudomonas Infections; Severity of Illness Index; Solutions; Tobramycin | 2005 |
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchiectasis; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; United Kingdom; United States | 2006 |
Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.
Topics: Administration, Inhalation; Aged; Anti-Bacterial Agents; Bronchiectasis; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Pseudomonas aeruginosa; Solutions; Sputum; Tobramycin | 2000 |
Treatment With tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa.
Topics: Adult; Aerosols; Bronchiectasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Pseudomonas Infections; Sputum; Staphylococcal Infections; Tobramycin; Treatment Outcome; Vital Capacity | 2001 |
9 other study(ies) available for tobramycin and Bronchiectasis
Article | Year |
---|---|
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis.
Topics: Adolescent; Bronchiectasis; Cystic Fibrosis; Fibrosis; Humans; Quality of Life; Tobramycin | 2022 |
Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Cross-Sectional Studies; Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Therapy; Retrospective Studies; Tobramycin | 2021 |
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.
Topics: Administration, Inhalation; Adult; Aged; Bronchiectasis; Cystic Fibrosis; Dose-Response Relationship, Drug; Dry Powder Inhalers; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Powders; Tobramycin | 2016 |
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchiectasis; Colony Count, Microbial; Drug Combinations; Drug Interactions; Fosfomycin; Humans; Lung; Male; Microbial Sensitivity Tests; Microbial Viability; Pneumonia, Bacterial; Rats; Tobramycin; Treatment Outcome | 2009 |
[Case reports of the treatment with tobramycin solution for inhalation in severe bronchiectasis patients continuous infection of Pseudomonas aeruginosa].
Topics: Administration, Inhalation; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Female; Humans; Middle Aged; Pseudomonas Infections; Respiratory Therapy; Tobramycin | 2005 |
Inhaled tobramycin: not just for cystic fibrosis anymore?
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Humans; Lung Diseases; Pseudomonas Infections; Tobramycin | 2005 |
[Clinical evaluation of the preparation Obracin].
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Drug Evaluation; Female; Humans; Male; Middle Aged; Pyelonephritis; Tobramycin | 1982 |
Tetany in a child with AIDS receiving intravenous tobramycin.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bronchiectasis; Child; Drug Monitoring; Female; Humans; Hypocalcemia; Hypokalemia; Kidney Diseases; Magnesium Deficiency; Pseudomonas Infections; Tetany; Tobramycin | 1996 |
[The relationship between different serological types of Pseudomonas aeruginosa strain in lower respiratory tract and its clinical significance].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchiectasis; Drug Resistance, Microbial; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Serotyping; Tobramycin | 1998 |